Canton Hathaway, LLC Astrazeneca PLC Transaction History
Canton Hathaway, LLC
- $400 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,374Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.1 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.79 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.55 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.63 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...